Dose of bisphosphonate for hypercalcaemia of malignancy. - Suppr | 超能文献

Dose of bisphosphonate for hypercalcaemia of malignancy.

作者信息

Morton A R, Friefeld J, Halperin F

出版信息

Lancet. 1990 Jun 16;335(8703):1469-70. doi: 10.1016/0140-6736(90)91503-3.

DOI:10.1016/0140-6736(90)91503-3

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Dose of bisphosphonate for hypercalcaemia of malignancy.

Lancet. 1990 Jun 16;335(8703):1469-70. doi: 10.1016/0140-6736(90)91503-3.

2

Overdosage of pamidronate in a patient with renal cell carcinoma.

Med Oncol. 2000 Nov;17(4):340-1. doi: 10.1007/BF02782202.

3

Bisphosphonate or RANK-L inhibitor for tumour-induced hypercalcaemia?双膦酸盐或RANK-L抑制剂用于治疗肿瘤引起的高钙血症？

Neth J Med. 2012 Jun;70(5):250-1.

4

Denosumab for the treatment of bisphosphonate-refractory hypercalcemia.地诺单抗用于治疗双膦酸盐难治性高钙血症。

J Clin Oncol. 2012 Oct 10;30(29):e299. doi: 10.1200/JCO.2012.41.7923. Epub 2012 Sep 4.

5

Infusion rate and pharmacokinetics of intravenous pamidronate in the treatment of tumour-induced hypercalcaemia.静脉注射帕米膦酸二钠治疗肿瘤所致高钙血症的输注速率及药代动力学

Postgrad Med J. 1992 Jun;68(800):434-9. doi: 10.1136/pgmj.68.800.434.

6

Immobilization hypercalcaemia responding to intravenous pamidronate sodium therapy.静脉注射帕米膦酸钠治疗有效的制动后高钙血症

Postgrad Med J. 1989 Apr;65(762):244-6. doi: 10.1136/pgmj.65.762.244.

7

Renal phosphate threshold and response to pamidronate in humoral hypercalcaemia of malignancy.

Lancet. 1989 Jul 29;2(8657):241-4. doi: 10.1016/s0140-6736(89)90429-7.

8

Intravenous pamidronate for hypercalcemia of primary hyperparathyroidism.静脉注射帕米膦酸盐治疗原发性甲状旁腺功能亢进症的高钙血症。

South Med J. 1996 Jun;89(6):637-40. doi: 10.1097/00007611-199606000-00020.

9

Single dose versus daily intravenous aminohydroxypropylidene biphosphonate (APD) for the hypercalcaemia of malignancy.单剂量与每日静脉注射氨基羟丙基二膦酸盐（APD）治疗恶性肿瘤高钙血症的比较

Br Med J (Clin Res Ed). 1988 Mar 19;296(6625):811-4. doi: 10.1136/bmj.296.6625.811.

10

The use of pamidronate in PTHrP associated hypercalcaemia in infancy.

J Pediatr Endocrinol Metab. 1997 May-Jun;10(3):301-4. doi: 10.1515/jpem.1997.10.3.301.

引用本文的文献

1

A combination of calcitonin and bisphosphonate for the emergency treatment of severe tumor-induced hypercalcemia.降钙素与双膦酸盐联合用于严重肿瘤诱导的高钙血症的紧急治疗。

Calcif Tissue Int. 1993 Jan;52(1):70-1. doi: 10.1007/BF00675630.

2

Drugs used in the treatment of metabolic bone disease. Clinical pharmacology and therapeutic use.用于治疗代谢性骨病的药物。临床药理学与治疗用途。

Drugs. 1993 Oct;46(4):594-617. doi: 10.2165/00003495-199346040-00003.

3

Factors predicting the acute effect of pamidronate on serum calcium in hypercalcemia of malignancy.

Calcif Tissue Int. 1992 Dec;51(6):419-23. doi: 10.1007/BF00296674.